These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
365 related items for PubMed ID: 9815856
1. Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells. Gupta M, Fan S, Zhan Q, Kohn KW, O'Connor PM, Pommier Y. Clin Cancer Res; 1997 Sep; 3(9):1653-60. PubMed ID: 9815856 [Abstract] [Full Text] [Related]
2. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines. Goldwasser F, Bae I, Fornace AJ, Pommier Y. Oncol Res; 1996 Sep; 8(7-8):317-23. PubMed ID: 8938795 [Abstract] [Full Text] [Related]
3. Correlations between S and G2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells. Goldwasser F, Shimizu T, Jackman J, Hoki Y, O'Connor PM, Kohn KW, Pommier Y. Cancer Res; 1996 Oct 01; 56(19):4430-7. PubMed ID: 8813137 [Abstract] [Full Text] [Related]
4. Acquired camptothecin resistance of human breast cancer MCF-7/C4 cells with normal topoisomerase I and elevated DNA repair. Fujimori A, Gupta M, Hoki Y, Pommier Y. Mol Pharmacol; 1996 Dec 01; 50(6):1472-8. PubMed ID: 8967967 [Abstract] [Full Text] [Related]
5. Caspase inhibition in camptothecin-treated U-937 cells is coupled with a shift from apoptosis to transient G1 arrest followed by necrotic cell death. Sané AT, Bertrand R. Cancer Res; 1999 Aug 01; 59(15):3565-9. PubMed ID: 10446962 [Abstract] [Full Text] [Related]
6. Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line. Urasaki Y, Laco GS, Pourquier P, Takebayashi Y, Kohlhagen G, Gioffre C, Zhang H, Chatterjee D, Pantazis P, Pommier Y. Cancer Res; 2001 Mar 01; 61(5):1964-9. PubMed ID: 11280753 [Abstract] [Full Text] [Related]
8. Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells. Sun SY, Yue P, Wu GS, El-Deiry WS, Shroot B, Hong WK, Lotan R. Cancer Res; 1999 Jun 15; 59(12):2829-33. PubMed ID: 10383141 [Abstract] [Full Text] [Related]
10. Topoisomerase I-related parameters and camptothecin activity in the colon carcinoma cell lines from the National Cancer Institute anticancer screen. Goldwasser F, Bae I, Valenti M, Torres K, Pommier Y. Cancer Res; 1995 May 15; 55(10):2116-21. PubMed ID: 7743511 [Abstract] [Full Text] [Related]
13. Complex response of breast epithelial cell lines to topoisomerase inhibitors. Davis PL, Shaiu WL, Scott GL, Iglehart JD, Hsieh TS, Marks JR. Anticancer Res; 1998 May 15; 18(4C):2919-32. PubMed ID: 9713486 [Abstract] [Full Text] [Related]
15. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells. Minko T, Paranjpe PV, Qiu B, Lalloo A, Won R, Stein S, Sinko PJ. Cancer Chemother Pharmacol; 2002 Aug 15; 50(2):143-50. PubMed ID: 12172980 [Abstract] [Full Text] [Related]
16. p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Havre PA, Yuan J, Hedrick L, Cho KR, Glazer PM. Cancer Res; 1995 Oct 01; 55(19):4420-4. PubMed ID: 7671255 [Abstract] [Full Text] [Related]
18. Identification of mutations at DNA topoisomerase I responsible for camptothecin resistance. Wang LF, Ting CY, Lo CK, Su JS, Mickley LA, Fojo AT, Whang-Peng J, Hwang J. Cancer Res; 1997 Apr 15; 57(8):1516-22. PubMed ID: 9108454 [Abstract] [Full Text] [Related]
19. Absence of a radiation-induced first-cycle G1-S arrest in p53+ human tumor cells synchronized by mitotic selection. Nagasawa H, Keng P, Maki C, Yu Y, Little JB. Cancer Res; 1998 May 01; 58(9):2036-41. PubMed ID: 9581850 [Abstract] [Full Text] [Related]